首页> 外文期刊>Journal of Pharmaceutical Analysis >Host cell protein quantification workflow using optimized standards combined with data-independent acquisition mass spectrometry
【24h】

Host cell protein quantification workflow using optimized standards combined with data-independent acquisition mass spectrometry

机译:使用优化标准品结合数据独立采集质谱法的宿主细胞蛋白定量工作流程

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Monitoring of host cell proteins (HCPs) during the manufacturing of monoclonal antibodies (mAb) has become a critical requirement to provide effective and safe drug products. Enzyme-linked immunosorbent assays are still the gold standard methods for the quantification of protein impurities. However, this technique has several limitations and does, among others, not enable the precise identification of proteins. In this context, mass spectrometry (MS) became an alternative and orthogonal method that delivers qualitative and quantitative information on all identified HCPs. However, in order to be routinely implemented in biopharmaceutical companies, liquid chromatography-MS based methods still need to be standardized to provide highest sensitivity and robust and accurate quantification. Here, we present a promising MS-based analytical workflow coupling the use of an innovative quantification standard, the HCP Profiler solution, with a spectral library-based data-independent acquisition (DIA) method and strict data validation criteria. The performances of the HCP Profiler solution were compared to more conventional standard protein spikes and the DIA approach was benchmarked against a classical data-dependent acquisition on a series of samples produced at various stages of the manufacturing process. While we also explored spectral library-free DIA interpretation, the spectral library-based approach still showed highest accuracy and reproducibility (coefficients of variation < 10) with a sensitivity down to the sub-ng/mg mAb level. Thus, this workflow is today mature to be used as a robust and straightforward method to support mAb manufacturing process developments and drug products quality control.
机译:在单克隆抗体 (mAb) 生产过程中监测宿主细胞蛋白 (HCP) 已成为提供有效和安全药品的关键要求。酶联免疫吸附测定仍然是定量蛋白质杂质的金标准方法。然而,这种技术有几个局限性,除其他外,不能精确识别蛋白质。在这种情况下,质谱法(MS)成为一种替代的正交方法,可以提供所有已鉴定的HCP的定性和定量信息。然而,为了在生物制药公司中常规实施,基于液相色谱-MS的方法仍然需要标准化,以提供最高的灵敏度和稳健准确的定量。在这里,我们提出了一种很有前途的基于MS的分析工作流程,该工作流程将创新的定量标准HCP Profiler解决方案与基于谱库的数据独立采集(DIA)方法和严格的数据验证标准相结合。将HCP Profiler解决方案的性能与更传统的标准蛋白质加标进行比较,并将DIA方法与在制造过程的各个阶段产生的一系列样品的经典数据相关采集进行基准测试。虽然我们还探索了无谱库的DIA解释,但基于谱库的方法仍然显示出最高的准确性和重现性(变异系数<10%),灵敏度低至亚ng/mg mAb水平。因此,该工作流程目前已经成熟,可以作为一种强大而直接的方法,用于支持mAb生产工艺开发和药品质量控制。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号